Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial.
Lancet Gastroenterol Hepatol
; 4(5): 354-363, 2019 05.
Article
in En
| MEDLINE
| ID: mdl-30880176
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Short Bowel Syndrome
/
Gastrointestinal Agents
/
Glucagon-Like Peptide 2
/
Intestinal Absorption
Type of study:
Clinical_trials
/
Guideline
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet Gastroenterol Hepatol
Year:
2019
Type:
Article